Key clinical point: The frequency of secondary Sjögren’s syndrome (sSS) increased with age and affected roughly about one-quarter of all SLE patients.
Major finding: SLE-sSS occurred in 23% of the SLE patients.
Study details: An analysis of 504 consecutive SLE patients and 319 controls from the general population.
Disclosures: The study was supported by funds from Swedish local and national governments, medical societies, foundations, and patient advocacy groups, One author is an employee at AstraZeneca, which provided reagents for the cytokine analyses but had no impact on the analyses, the authors said.
Ruacho G et al. J Rheumatol. 2019 Sep 1. doi: 10.3899/jrheum.190250.